mrx34
Nucleic acidexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2013 (NCT01829971)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- MicroRNA 34Supplementation
MicroRNA 34 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- mrx34
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02862145 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2016 | Mirna Therapeutics |
| NCT01829971 | Phase 1 | Apr 1, 2013 | Mirna Therapeutics, State of Texas |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mirna Therapeutics | For profit | 2 | 2 | 2 | 2013 |
| State of Texas | Government | 1 | 0 | 1 | 2013 |
2 organizations
Page 1 / 1